中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2010年
3期
353-355
,共3页
洪信强%牛伟新%胡健卫%许剑民%秦新裕
洪信彊%牛偉新%鬍健衛%許劍民%秦新裕
홍신강%우위신%호건위%허검민%진신유
结肠肿瘤%树突细胞%Toll样受体%癌胚抗原
結腸腫瘤%樹突細胞%Toll樣受體%癌胚抗原
결장종류%수돌세포%Toll양수체%암배항원
Colonic neoplasms%Dendritic cells%Toll-Like receptors%Carcinoembryonic antigen
目的 观察联合激动Toll样受体(TLR)能否使树突细胞(OC)达到更理想的成熟状态,并诱导出抗结肠癌免疫反应.方法 在体外培养DC过程中加入TLR3和TLR7/8配体,流式细胞仪检测Dc重要表型表达,酶联免疫吸附实验(ELISA)法检测白细胞介素(IL)-12分泌量,~3H-thymidine掺入法检测DC促淋巴细胞增殖能力,使用CEA转基因鼠和转染CEA的MC38小鼠结肠癌细胞株(MC38-CEA)构建动物模型,乳酸脱氢酶(LDH)释放法检测DC诱导细胞毒性T淋巴细胞(CTL)对MC38-CEA的体外杀伤作用.结果 联合激动TLR的DC与常规组比较,能高水平表达DC重要表型,分泌更多IL-12(P<0.01),更有效刺激淋巴细胞增殖(P<0.01),荷载抗原后诱导的效应细胞在效靶比为20:1和40:1时,对MC38-CEA的杀伤率为(31.9±3.3)%和(39.1±4.2)%,而其他各组无明显杀伤作用(P<0.05).结论 联合激动TLR的DC具有更理想的成熟度,能诱导更有效的抗肠癌免疫反应,提示联合激动TLR可能是增强DC肿瘤疫苗疗效的有效途径.
目的 觀察聯閤激動Toll樣受體(TLR)能否使樹突細胞(OC)達到更理想的成熟狀態,併誘導齣抗結腸癌免疫反應.方法 在體外培養DC過程中加入TLR3和TLR7/8配體,流式細胞儀檢測Dc重要錶型錶達,酶聯免疫吸附實驗(ELISA)法檢測白細胞介素(IL)-12分泌量,~3H-thymidine摻入法檢測DC促淋巴細胞增殖能力,使用CEA轉基因鼠和轉染CEA的MC38小鼠結腸癌細胞株(MC38-CEA)構建動物模型,乳痠脫氫酶(LDH)釋放法檢測DC誘導細胞毒性T淋巴細胞(CTL)對MC38-CEA的體外殺傷作用.結果 聯閤激動TLR的DC與常規組比較,能高水平錶達DC重要錶型,分泌更多IL-12(P<0.01),更有效刺激淋巴細胞增殖(P<0.01),荷載抗原後誘導的效應細胞在效靶比為20:1和40:1時,對MC38-CEA的殺傷率為(31.9±3.3)%和(39.1±4.2)%,而其他各組無明顯殺傷作用(P<0.05).結論 聯閤激動TLR的DC具有更理想的成熟度,能誘導更有效的抗腸癌免疫反應,提示聯閤激動TLR可能是增彊DC腫瘤疫苗療效的有效途徑.
목적 관찰연합격동Toll양수체(TLR)능부사수돌세포(OC)체도경이상적성숙상태,병유도출항결장암면역반응.방법 재체외배양DC과정중가입TLR3화TLR7/8배체,류식세포의검측Dc중요표형표체,매련면역흡부실험(ELISA)법검측백세포개소(IL)-12분비량,~3H-thymidine참입법검측DC촉림파세포증식능력,사용CEA전기인서화전염CEA적MC38소서결장암세포주(MC38-CEA)구건동물모형,유산탈경매(LDH)석방법검측DC유도세포독성T림파세포(CTL)대MC38-CEA적체외살상작용.결과 연합격동TLR적DC여상규조비교,능고수평표체DC중요표형,분비경다IL-12(P<0.01),경유효자격림파세포증식(P<0.01),하재항원후유도적효응세포재효파비위20:1화40:1시,대MC38-CEA적살상솔위(31.9±3.3)%화(39.1±4.2)%,이기타각조무명현살상작용(P<0.05).결론 연합격동TLR적DC구유경이상적성숙도,능유도경유효적항장암면역반응,제시연합격동TLR가능시증강DC종류역묘료효적유효도경.
Objective To investigate the immune functions of DCs with synergistic activation of TLR ligands and the antitumor effects against colon cancer induced by DCs in vitro.Methods We involved combination of TLR ligands in culture protocol of DCs.The DCs'important surface molecules expression was detected by flow cytometry.DCs'IL-12 secretion was evaluated by ELISA and the proliferating capacity of lymphocytes was tested by ~3H-thymidine assay.The CEA tramgenic mice and MC38-CEA mmouse colon cancer cell line were employed as animal model and the CTL activity against MC38-CEA induced by pulsed DCs was tested by LDH cytotoxicity assay.Results Compared with conventional generated DCs,DCs combined with activation of TLR showed higher surface molecules expression,significantly higher secretion of IL-12 and more potent proliferating capacity of lymphocytes as well.The cytolytic activity against MC38-CEA cells shown by effector cells induced by pulsed DCs with combined activation of TLR was(31.9±3.3)%and(39.1±4.2)%when the E:T ratio was 20:1 and 40:1 respectively,but no obvious cytolytic activity was found showed in other groups.Conclusion DCs combined with activation of TLR showed better maturation status and can also induce more effective antitumor immune effects against colon cancer,suggesting combined aetivation of TLR may be the effective strategy for developing more powerful Dt2s cancer vaccines.